Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Short term Debt (2022 - 2025)

DarioHealth filings provide 4 years of Short term Debt readings, the most recent being $10.3 million for Q1 2025.

  • On a quarterly basis, Short term Debt rose 160.37% to $10.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was $10.3 million, a 160.37% increase, with the full-year FY2024 number at $5.5 million, up 37.86% from a year prior.
  • Short term Debt hit $10.3 million in Q1 2025 for DarioHealth, up from $5.5 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $10.3 million in Q1 2025 to a low of $373000.0 in Q1 2022.
  • Median Short term Debt over the past 4 years was $5.2 million (2024), compared with a mean of $5.3 million.
  • The widest YoY moves for Short term Debt: up 2201.07% in 2023, down 55.19% in 2023.
  • DarioHealth's Short term Debt stood at $8.8 million in 2022, then crashed by 55.19% to $4.0 million in 2023, then soared by 37.86% to $5.5 million in 2024, then surged by 88.86% to $10.3 million in 2025.
  • The last three reported values for Short term Debt were $10.3 million (Q1 2025), $5.5 million (Q4 2024), and $8.7 million (Q3 2024) per Business Quant data.